Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in North Macedonia

North Macedonia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 15.0% in 2021. ▼ Falling

Latest (2021)
15.0%
Change on year
down 2.0%
World rank
100th
of 185 countries
All-time high
20.5%
in 2000
All-time low
15.0%
in 2021
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in North Macedonia, 2000–2021

051015202000201020212000: 20.5 %2001: 19.4 %2002: 19.8 %2003: 19.4 %2004: 19.1 %2005: 19 %2006: 19.3 %2007: 19.6 %2008: 18.6 %2009: 17.9 %2010: 17.3 %2011: 17.5 %2012: 17 %2013: 16.1 %2014: 16.6 %2015: 16.7 %2016: 16 %2017: 15.4 %2018: 15.5 %2019: 15.8 %2020: 15.3 %2021: 15 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

In 2021, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in North Macedonia stood at 15.0%. That is the lowest value across all 22 years on record.

The figure is down 2.0% on the previous year and down 14.3% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in North Macedonia peaked at 20.5% in 2000 and was at its lowest, 15.0%, in 2021.

North Macedonia ranks 100th of 185 countries on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in North Macedonia, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in North Macedonia, 2000 to 2021.
Year % Change
2000 20.5%
2001 19.4% -5.4%
2002 19.8% +2.1%
2003 19.4% -2.0%
2004 19.1% -1.5%
2005 19.0% -0.5%
2006 19.3% +1.6%
2007 19.6% +1.6%
2008 18.6% -5.1%
2009 17.9% -3.8%
2010 17.3% -3.4%
2011 17.5% +1.2%
2012 17.0% -2.9%
2013 16.1% -5.3%
2014 16.6% +3.1%
2015 16.7% +0.6%
2016 16.0% -4.2%
2017 15.4% -3.7%
2018 15.5% +0.6%
2019 15.8% +1.9%
2020 15.3% -3.2%
2021 15.0% -2.0%

North Macedonia compared with similar countries

  • North Macedonia's 15.0% is below the median for upper middle income countries, which is 15.1%, 99% of the median. (55 countries reporting)
  • North Macedonia's 15.0% is above the median for Europe & Central Asia, which is 10.4%, 1.4× the median. (48 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 19.3% 17.9% 20.5% 10
2010s 16.4% 15.4% 17.5% 10
2020s 15.2% 15.0% 15.3% 2

Countries ranked near North Macedonia

  1. 98 Venezuela, Bolivarian Republic of 15.2% compare
  2. 99 Azerbaijan 15.1% compare
  3. 100 Hungary 15.0% compare
  4. 102 Bhutan 14.7% compare
  5. 102 Russian Federation 14.7% compare

See the full ranking of 232 places →

More health data for North Macedonia

All data for North Macedonia →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in North Macedonia?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in North Macedonia was 15.0% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in North Macedonia?
The highest recorded value was 20.5% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in North Macedonia?
The lowest recorded value was 15.0% in 2021.
How does North Macedonia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
North Macedonia ranks 100th out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in North Macedonia?
Over the last ten years it is down 14.3%. The long-run trend across the full record is falling.
Where does this North Macedonia data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in North Macedonia. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 15 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/north-macedonia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/north-macedonia/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in North Macedonia</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).